Orange Book product · Brand (NDA)
DYAZIDE
HYDROCHLOROTHIAZIDE; TRIAMTERENE
At a glance
Mar 03, 1994
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 03, 1994
32 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength
25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 016042
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1984MAXZIDEBrand (NDA)
NDA 019129 · AUROBINDO PHARMA USA
- 2025TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 214611 · MACLEODS PHARMS LTD
- 2022TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 216211 · RUBICON RESEARCH
- 2019TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208358 · CADILA
- 2018TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208360 · ZYDUS PHARMS
- 2011TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 201407 · LANNETT CO INC
- 1999TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 075052 · DURAMED PHARMS BARR
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 071251 · APOTEX INC
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074970 · ANI PHARMS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074857 · NOVARTIS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074821 · SANDOZ
- 1996TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074701 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
